Skip to content

Antisense oligonucleotide mediated exon skipping therapy development for Duchenne muscular dystrophy takes more than an oligonucleotide

Pharmacology seminar by Annemieke Aartsma-Rus, Leiden University Medical Center, the Netherlands

Hosted by ERN-RND

Tuesday 15:00–16:10 London (GMT+1)

Recording available

ZA Leiden, Netherlands · Hybrid

We use cookies for analytics.